Announcements Trials
Browse Landscape

Status

Completed 3Unknown 1Recruiting 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1Other hematologic neoplasm 1Gynecologic 1Gastrointestinal 1

Conditions

Osteochondroma 1Non-alcoholic Fatty Liver Disease 1Nevus, Epithelioid and Spindle Cell 1Lung Neoplasms 1Hematologic Neoplasms 1Giant Cell Tumors 1Fibrosis 1Endometrial Hyperplasia 1Carcinoma, Lobular 1Carcinoma in Situ 1Barrett Esophagus 1

Interventions

Magnetic Resonance Spectroscopy 332Specimen Handling 331Radiotherapy 315Cyclophosphamide 298pembrolizumab 286Cisplatin 270Carboplatin 247Drug Therapy 238Blood Specimen Collection 234Biopsy 203Bevacizumab 185Gemcitabine 181venetoclax 177Radiosurgery 170Oxaliplatin 164Capecitabine 163fludarabine 161Paclitaxel 158Nivolumab 157Standard of Care 135Surveys and Questionnaires 132Surgical Procedures, Operative 130Dexamethasone 126Fluorouracil 123Rituximab 113Docetaxel 112tislelizumab 111Cytarabine 106toripalimab 101Radiation 101

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × OTHER × Sampling Studies × Clear all
NCT05463796 2025-08-07

InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer

Dana-Farber Cancer Institute

Recruiting
5,000 enrolled
GastrointestinalGynecologicOther hematologic neoplasmThoracic

Barrett Esophagus, Carcinoma in Situ, Endometrial Hyperplasia, Fibrosis, Giant Cell Tumors, Lung Neoplasms, Osteochondroma, Carcinoma, Lobular, Nevus, Epithelioid and Spindle Cell, Hematologic Neoplasms, Non-alcoholic Fatty Liver Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡